Search Results - Harichand-Herdt, S

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    A randomized phase II trial of preoperative docetaxel (D) and capecitabine (C) given sequentially or concurrently for Her2 negative breast cancers

    A randomized phase II trial of preoperative docetaxel (D) and capecitabine (C) given sequentially or concurrently for Her2 negative breast cancers by Harichand-Herdt, S, Zelnak, A, Styblo, T, Rizzo, M, Gabram, S, Bumpers, H, D'Orsi, C, Carlson, K, Senior-Crosby, D, Sellers, N, Pierce, T, Hicklin, D, Srinivasiah, J, Schnell, F, Hermann, R, O'Regan, R

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Targeted Therapy for the Treatment of Non-Small Cell Lung Cancer: Focus on Inhibition of Epidermal Growth Factor Receptor

    Targeted Therapy for the Treatment of Non-Small Cell Lung Cancer: Focus on Inhibition of Epidermal Growth Factor Receptor by Harichand-Herdt, Seema, MD, Ramalingam, Suresh S., MD

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Final Results from Phase II Trial of Neoadjuvant Docetaxel and Capecitabine Given Sequentially or Concurrently for HER2-Negative Breast Cancers

    Final Results from Phase II Trial of Neoadjuvant Docetaxel and Capecitabine Given Sequentially or Concurrently for HER2-Negative Breast Cancers by Zelnak, Amelia B, Styblo, Toncred M, Rizzo, Monica, Gabram, Sheryl G, Wood, William C, Harichand-Herdt, Seema, Kim, Sungjin, Liu, Yuan, O'Regan, Ruth M

    Published in Clinical breast cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: